null Option on Hookipa Pharma
| HOOK Stock | USD 1.14 0.03 2.56% |
Hookipa Pharma's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 2.72 with a put-to-call open interest ratio of 0.04 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on October 17th 2025.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows Hookipa Pharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Hookipa Pharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Hookipa Pharma's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Hookipa Pharma
Analyzing Hookipa Pharma's in-the-money options over time can help investors to take a profitable long position in Hookipa Pharma regardless of its overall volatility. This is especially true when Hookipa Pharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Hookipa Pharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Hookipa Pharma's stock while costing only a fraction of its price.
Hookipa Current Options Market Mood
Hookipa Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Hookipa Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Hookipa Pharma's options investors are not very successful. Hookipa Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Hookipa contract
Base on the Rule 16, the options market is currently suggesting that Hookipa Pharma will have an average daily up or down price movement of about 0.17% per day over the life of the 2025-10-17 option contract. With Hookipa Pharma trading at USD 1.14, that is roughly USD 0.001938. If you think that the market is fully incorporating Hookipa Pharma's daily price movement you should consider buying Hookipa Pharma options at the current volatility level of 2.72%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Hookipa Pharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Hookipa calls. Remember, the seller must deliver Hookipa Pharma stock to the call owner when a call is exercised.
Hookipa Pharma Option Chain
When Hookipa Pharma's strike price is surpassing the current stock price, the option contract against Hookipa Pharma stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Hookipa Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Hookipa. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Hookipa. It also shows strike prices and maturity days for a Hookipa Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | HOOK251017C00007500 | 0 | 7.5 | 0.0 - 0.35 | 0.35 | |
Call | HOOK251017C00005000 | 0 | 5.0 | 0.0 - 0.15 | 0.15 | |
Call | HOOK251017C00002500 | 90 | 2.5 | 0.05 - 0.1 | 0.05 | Out |
Put | HOOK251017P00007500 | 0 | 7.5 | 5.3 - 8.8 | 5.74 | In |
Put | HOOK251017P00005000 | 4 | 5.0 | 3.9 - 4.2 | 3.6 | In |
Put | HOOK251017P00002500 | 0 | 2.5 | 0.0 - 1.5 | 1.5 | In |
Hookipa Pharma Market Cap Over Time
Market Cap |
| Timeline |
Hookipa Total Stockholder Equity
Total Stockholder Equity |
|
Hookipa Pharma Corporate Management
| Lukas Flatz | CoFounder | Profile | |
| Klaus Orlinger | Chief Officer | Profile | |
| Reinhard Kandera | CFO Director | Profile | |
| Matthew Beck | Executive Relations | Profile | |
| Mark Winderlich | Chief Officer | Profile | |
| Joern Aldag | CEO Director | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.85) | Revenue Per Share | Quarterly Revenue Growth (0.94) | Return On Assets | Return On Equity |
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.